Deep search
Search
Images
Copilot
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Venture Global LNG Raises $1.75 Billion in IPO
Venture Global LNG raises $1.75 billion after pricing US IPO
Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering within range, the second-largest exporter of liquefied natural gas in the United States said on Thursday. The company priced its offering of 70 million shares at $25 each,
US producer Venture Global LNG raises $1.75bn from IPO
Expansion plans could make company second largest emitter of greenhouse gases from LNG export terminals by 2030, report claims
US energy group Venture Global notches up $60bn valuation in IPO
The company priced its IPO at $25 a share, raising $1.75bn, according to a statement. It had said earlier this month that it was seeking to achieve a valuation of up to $110bn — more than oil major BP — before scaling back its offering this week.
Ascentage Pharma’s US Shares Climb
Ascentage Pharma’s US Shares Climb After $126 Million IPO
Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut after pricing its $126.4 million initial public offering at a discount to its Asian stock.
Takeda-backed Ascentage Pharma aims to raise $126 million in US IPO
Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.
Takeda-backed Ascentage Pharma prices $126M U.S. IPO
Ascentage Pharma Group (AAPG) (AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), has priced a $126M U.S. initial public offering. The China-based drug developer priced 7.33M shares at $17.25 per share,
8h
IPO market comeback: How recent major US listings fared
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
1h
What to Know About the Pork IPO That Could Kick Off 2025 With a Bang
Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise as much as $940 million as it returns to the stock market.
3h
2024 Year In Review: IPO Market Overview
In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...
Upstream
5h
US LNG player set to begin life on stock market with $1.75 billion target
Venture Global expects to begin trading on Friday on the New York Stock Exchange with an initial public offering (IPO) priced ...
2d
Cathie Wood Sees Trump Agenda Reviving US IPOs
Cathie Wood is betting Donald Trump’s regulatory and growth agenda will revive the market for US initial public offerings.
2h
Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
3d
Smithfield Foods seeks up to $10.7 billion valuation in US IPO
Smithfield Foods is targeting a valuation of up to $10.73 billion in its New York flotation, the biggest U.S. pork processor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback